The invention relates to new thiadiazolyl or thiazolyl-substituted cephem and cepham compounds, the pharmaceutically acceptable salts and bioprecursors thereof, of antimicrobial activity, processes for preparation thereof, intermediates for preparing the new compounds and to pharmaceutical compositions comprising the new compounds, and methods of using the compositions for treatment of infectious diseases.
本发明涉及具有抗菌活性的新型
噻二唑基或
噻唑基取代的头孢烯和头霉素化合物、其药学上可接受的盐和
生物前体、制备这些化合物的方法、制备新化合物的中间体,以及包含这些新化合物的药物组合物,以及使用这些组合物治疗感染性疾病的方法。